Insider · CIK 0001653133
Benjamin Harshbarger
Files at ATXS (Astria Therapeutics, Inc.). First filing -, latest -.
Benjamin Harshbarger files SEC Form 4 as officer at ATXS (Astria Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Benjamin Harshbarger has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -33,333 | - | - | 0 | Jan 23, 2026 |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -55,000 | - | - | 0 | Jan 23, 2026 |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -262,500 | - | - | 0 | Jan 23, 2026 |
| Mar 21, 2025 | ATXS Astria Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +262,500 | $0.00 | $0 | 262,500 | Mar 25, 2025 |
Questions about Benjamin Harshbarger
Answered from the filings on this page, as of the latest one.
Is Benjamin Harshbarger buying or selling?
Benjamin Harshbarger has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Benjamin Harshbarger's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Benjamin Harshbarger has 0.
Where does Benjamin Harshbarger file Form 4?
Benjamin Harshbarger has filed Form 4 at ATXS (Astria Therapeutics, Inc.) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.